People Background Check
Find People:

David C Sternberg Deceased3205 Breton Ave, Davis, CA 95616

Get Report
Known as:
David Charles Sternberg Dave Sternberg
Related to:
Jennifer M Vyvyan 50 Joan M Orland 78

David Sternberg Phones & Addresses

3205 Breton Ave, Davis, CA 95616 (530) 757-6623

56 Mountain Rd, Redding, CT 06896

3205 Breton Ave, Davis, CA 95616 (530) 219-8275

Work

Position: Service Occupations

Education

Degree: Associate degree or higher

Emails

d***[email protected]

Mentions for David C Sternberg

Career records & work history

Lawyers & Attorneys

David Sternberg Photo 1

David Sternberg - Lawyer

Office:
David M. Sternberg & Associates
Specialties:
Civil Litigation, Bankruptcy & Debt, Creditors' Rights, Real Estate, Probate, Business, Litigation
ISLN:
903423784
Admitted:
1980
University:
Antioch College, B.A., 1974
Law School:
Golden Gate University, J.D., 1980
David Sternberg Photo 2

David Sternberg - Lawyer

Office:
David M. Sternberg & Associates
Specialties:
Civil Litigation, Bankruptcy & Debt, Creditors' Rights, Real Estate, Probate, Business, Litigation
ISLN:
903423784
Admitted:
1980
University:
Antioch College, B.A., 1974
Law School:
Golden Gate University, J.D., 1980

Medicine Doctors

David E. Sternberg

Specialties:
Psychiatry, Addiction Psychiatry
Work:
Psychiatry Associates Chartered
527 SW Market St, Lees Summit, MO 64063
(913) 209-9495 (phone) (913) 498-0523 (fax)
Education:
Medical School
Tufts University School of Medicine
Graduated: 1971
Procedures:
Psychiatric Therapeutic Procedures
Conditions:
Anxiety Dissociative and Somatoform Disorders, Anxiety Phobic Disorders, Attention Deficit Disorder (ADD), Bipolar Disorder, Depressive Disorders, Obsessive-Compulsive Disorder (OCD), Post Traumatic Stress Disorder (PTSD)
Languages:
English
Description:
Dr. Sternberg graduated from the Tufts University School of Medicine in 1971. He works in Lee's Summit, MO and specializes in Psychiatry and Addiction Psychiatry. Dr. Sternberg is affiliated with Northwest Missouri Psychiatric Rehabilitation Center and St Joseph Medical Center.
David Sternberg Photo 3

David William Sternberg

Specialties:
Internal Medicine
Hematology & Oncology
Hematology
Medical Oncology
Education:
Cornell University (1993)

David Sternberg resumes & CV records

Resumes

David Sternberg Photo 53

David Sternberg

David Sternberg Photo 54

David Sternberg

David Sternberg Photo 55

David Sternberg

David Sternberg Photo 56

Avp At First National Bank Of Sparta

Position:
Assistant VP at First National Bank of Sparta
Location:
Sparta, Illinois
Industry:
Banking
Work:
First National Bank of Sparta - First National Bank of Sparta since Mar 2012
Assistant VP Midland States Bank Feb 2009 - Oct 2009
Banking Center Manager Commercial State Bank of Waterloo Jan 2004 - Feb 2009
Branch Manager
Education:
University of Colorado at Boulder 2001 - 2003
Southern Illinois University, Carbondale 1997 - 2000
ba, Finance, Managment,
Skills:
Retail Banking, Banking, Loans, Credit Analysis, Commercial Lending
Interests:
investing, banking, lending,
David Sternberg Photo 57

David Sternberg

Location:
United States

Publications & IP owners

Us Patents

Methods For Producing Biological Substances In Pigment-Deficient Mutants Of Cells

US Patent:
7476516, Jan 13, 2009
Filed:
Jul 25, 2003
Appl. No.:
10/627124
Inventors:
Maria Tang - Fairfield CA, US
Alan Sloma - Davis CA, US
David Sternberg - Davis CA, US
Regine Behr - Roseville CA, US
Assignee:
Novozymes, Inc. - Davis CA
International Classification:
C12P 21/06
US Classification:
435 691, 435 693, 435 697, 435 711, 435243, 4352521, 4352523, 43525231
Abstract:
The present invention relates to methods of producing a heterologous biological substance, comprising: (a) cultivating a mutant of a parent cell under conditions conducive for the production of the heterologous biological substance, wherein (i) the mutant cell comprises a first nucleic acid sequence directing synthesis of the heterologous biological substance and a second nucleic acid sequence comprising a modification of at least one of the genes cypX and yvmC, which are involved in the production of a red pigment, and (ii) the mutant cell is deficient in the production of the red pigment compared to the parent cell when cultivated under the same conditions; and (b) recovering the heterologous biological substance from the cultivation medium. The present invention also relates to mutants of cells and methods for producing the mutants.

Methods For Producing Biological Substances In Pigment-Deficient Mutants Of Cells

US Patent:
7666625, Feb 23, 2010
Filed:
Dec 9, 2008
Appl. No.:
12/331323
Inventors:
Maria Tang - Fairfield CA, US
Alan Sloma - Davis CA, US
David Sternberg - Davis CA, US
Linda Sternberg, legal representative - Davis CA, US
Regine Behr - Roseville CA, US
Assignee:
Novozymes, Inc. - Davis CA
International Classification:
C12P 21/06
US Classification:
435 691, 435 693, 435 697, 435 711, 435243, 4352521, 4352523, 43525231
Abstract:
The present invention relates to methods of producing a heterologous biological substance, comprising: (a) cultivating a mutant of a parent cell under conditions conducive for the production of the heterologous biological substance, wherein (i) the mutant cell comprises a first nucleic acid sequence directing synthesis of the heterologous biological substance and a second nucleic acid sequence comprising a modification of at least one of the genes cypX and yvmC, which are involved in the production of a red pigment, and (ii) the mutant cell is deficient in the production of the red pigment compared to the parent cell when cultivated under the same conditions; and (b) recovering the heterologous biological substance from the cultivation medium. The present invention also relates to mutants of cells and methods for producing the mutants.

Methods For Producing Hyaluronan In A Recombinant Host Cell

US Patent:
7811806, Oct 12, 2010
Filed:
Dec 20, 2002
Appl. No.:
10/326185
Inventors:
Alan Sloma - Davis CA, US
Regine Behr - Roseville CA, US
William Widner - Davis CA, US
Maria Tang - Fairfield CA, US
David Sternberg - Davis CA, US
Stephen Brown - Davis CA, US
Assignee:
Novozymes, Inc. - Davis CA
International Classification:
C12N 1/20
C12N 15/74
C12N 15/00
C12P 21/06
C12P 19/04
C12P 19/26
US Classification:
43525231, 435471, 4353201, 435 691, 435101, 435 84
Abstract:
The present invention relates to methods for producing a hyaluronic acid, comprising: (a) cultivating a host cell under conditions suitable for production of the hyaluronic acid, wherein the host cell comprises a nucleic acid construct comprising a hyaluronan synthase encoding sequence operably linked to a promoter sequence foreign to the hyaluronan synthase encoding sequence; and (b) recovering the hyaluronic acid from the cultivation medium. The present invention also relates to an isolated nucleic acid sequence encoding a hyaluronan synthase operon comprising a hyaluronan synthase gene and a UDP-glucose 6-dehydrogenase gene, and optionally one or more genes selected from the group consisting of a UDP-glucose pyrophosphorylase gene, UDP-N-acetylglucosamine pyrophosphorylase gene, and glucose-6-phosphate isomerase gene. The present invention also relates to isolated nucleic acid sequences encoding a UDP-glucose 6-dehydrogenase, UDP-glucose pyrophosphorylase, and UDP-N-acetylglucosamine pyrophosphorylase.

Methods For Producing Hyaluronan In A Recombinant Host Cell

US Patent:
8093036, Jan 10, 2012
Filed:
Sep 27, 2010
Appl. No.:
12/891548
Inventors:
Alan Sloma - Davis CA, US
Leslie Naggiar, legal representative - Suffern NY, US
Regine Behr - Roseville CA, US
William Widner - Davis CA, US
Maria Tang - Fairfield CA, US
David Sternberg - Davis CA, US
Linda Sternberg, legal representative - Davis CA, US
Stephen Brown - Davis CA, US
Assignee:
Novozymes, Inc. - Davis CA
International Classification:
C12N 1/20
C12N 15/74
C12N 15/00
C12P 21/06
C12P 19/04
C12P 19/36
C12P 1/00
C12N 9/00
C12N 9/24
C12N 9/88
C07H 21/04
US Classification:
43525231, 435471, 4353201, 435 691, 435101, 435 84, 435 41, 435183, 435200, 435232, 4352523, 536 232, 536 231
Abstract:
The present invention relates to methods for producing a hyaluronic acid, comprising: (a) cultivating a host cell under conditions suitable for production of the hyaluronic acid, wherein the host cell comprises a nucleic acid construct comprising a hyaluronan synthase encoding sequence operably linked to a promoter sequence foreign to the hyaluronan synthase encoding sequence; and (b) recovering the hyaluronic acid from the cultivation medium. The present invention also relates to an isolated nucleic acid sequence encoding a hyaluronan synthase operon comprising a hyaluronan synthase gene and a UDP-glucose 6-dehydrogenase gene, and optionally one or more genes selected from the group consisting of a UDP-glucose pyrophosphorylase gene, UDP-N-acetylglucosamine pyrophosphorylase gene, and glucose-6-phosphate isomerase gene. The present invention also relates to isolated nucleic acid sequences encoding a UDP-glucose 6-dehydrogenase, UDP-glucose pyrophosphorylase, and UDP-N-acetylglucosamine pyrophosphorylase.

Methods For Producing Biological Substances In Pigment-Deficient Mutants Of Cells

US Patent:
8124376, Feb 28, 2012
Filed:
Feb 10, 2010
Appl. No.:
12/703550
Inventors:
Maria Tang - Fairfield CA, US
Alan Sloma - Davis CA, US
Leslie Naggiar, legal representative - Suffern NY, US
David Sternberg - Davis CA, US
Linda Sternberg, legal representative - Davis CA, US
Regine Behr - Roseville CA, US
Assignee:
Novozymes, Inc. - Davis CA
International Classification:
C12P 21/06
US Classification:
435 691, 435243, 4352521, 4352523, 43525231, 435 693, 435 697, 435 711
Abstract:
The present invention relates to methods of producing a heterologous biological substance, comprising: (a) cultivating a mutant of a parent cell under conditions conducive for the production of the heterologous biological substance, wherein (i) the mutant cell comprises a first nucleic acid sequence directing synthesis of the heterologous biological substance and a second nucleic acid sequence comprising a modification of at least one of the genes cypX and yvmC, which are involved in the production of a red pigment, and (ii) the mutant cell is deficient in the production of the red pigment compared to the parent cell when cultivated under the same conditions; and (b) recovering the heterologous biological substance from the cultivation medium. The present invention also relates to mutants of cells and methods for producing the mutants.

Methods For Producing Hyaluronan In A Recombinant Host Cell

US Patent:
8137951, Mar 20, 2012
Filed:
Apr 11, 2011
Appl. No.:
13/084230
Inventors:
Alan Sloma - Davis CA, US
Leslie Naggiar, legal representative - Suffern NY, US
Regine Behr - Roseville CA, US
William Widner - Davis CA, US
Maria Tang - Fairfield CA, US
David Sternberg - Davis CA, US
Linda Sternberg, legal representative - Davis CA, US
Stephen Brown - Davis CA, US
Assignee:
Novozymes, Inc. - Davis CA
International Classification:
C12N 1/20
C12N 15/74
C12N 15/00
C12P 21/00
C12P 9/26
C12P 1/00
C12N 9/00
C12N 9/24
C12N 9/88
C07H 21/04
US Classification:
43525231, 4352523, 435471, 4353201, 435 691, 435101, 435 84, 435 41, 435183, 435200, 435232, 536 232, 536 237
Abstract:
The present invention relates to methods for producing a hyaluronic acid, comprising: (a) cultivating a host cell under conditions suitable for production of the hyaluronic acid, wherein the host cell comprises a nucleic acid construct comprising a hyaluronan synthase encoding sequence operably linked to a promoter sequence foreign to the hyaluronan synthase encoding sequence; and (b) recovering the hyaluronic acid from the cultivation medium. The present invention also relates to an isolated nucleic acid sequence encoding a hyaluronan synthase operon comprising a hyaluronan synthase gene and a UDP-glucose 6-dehydrogenase gene, and optionally one or more genes selected from the group consisting of a UDP-glucose pyrophosphorylase gene, UDP-N-acetylglucosamine pyrophosphorylase gene, and glucose-6-phosphate isomerase gene. The present invention also relates to isolated nucleic acid sequences encoding a UDP-glucose 6-dehydrogenase, UDP-glucose pyrophosphorylase, and UDP-N-acetylglucosamine pyrophosphorylase.

Methods For Producing Hyaluronan In A Recombinant Host Cell

US Patent:
2012014, Jun 14, 2012
Filed:
Feb 21, 2012
Appl. No.:
13/401663
Inventors:
Alan Sloma - Davis CA, US
Leslie Naggiar - Suffern NY, US
Regine Behr - Roseville CA, US
William Widner - Davis CA, US
Maria Tang - Fairfield CA, US
David Sternberg - Davis CA, US
Linda Sternberg - Davis CA, US
Stephen Brown - Davis CA, US
Assignee:
Novozymes, Inc. - Davis CA
International Classification:
C12P 19/28
US Classification:
435 85
Abstract:
The present invention relates to methods for producing a hyaluronic acid, comprising: (a) cultivating a host cell under conditions suitable for production of the hyaluronic acid, wherein the host cell comprises a nucleic acid construct comprising a hyaluronan synthase encoding sequence operably linked to a promoter sequence foreign to the hyaluronan synthase encoding sequence; and (b) recovering the hyaluronic acid from the cultivation medium. The present invention also relates to an isolated nucleic acid sequence encoding a hyaluronan synthase operon comprising a hyaluronan synthase gene and a UDP-glucose 6-dehydrogenase gene, and optionally one or more genes selected from the group consisting of a UDP-glucose pyrophosphorylase gene, UDP-N-acetylglucosamine pyrophosphorylase gene, and glucose-6-phosphate isomerase gene. The present invention also relates to isolated nucleic acid sequences encoding a UDP-glucose 6-dehydrogenase, UDP-glucose pyrophosphorylase, and UDP-N-acetylglucosamine pyrophosphorylase

Methods For Producing Hyaluronan In A Recombinant Host Cell

US Patent:
2014003, Feb 6, 2014
Filed:
Oct 10, 2013
Appl. No.:
14/050866
Inventors:
- Bagsvaerd, DK
Regine Behr - Roseville CA, US
William Widner - Davis CA, US
Stephen Brown - Davis CA, US
Maria Tang - Fairfield CA, US
David Sternberg - Davis CA, US
Assignee:
Novozymes Biopharma DK A/S - Bagsvaerd
International Classification:
C12P 19/26
US Classification:
435 84, 43525231
Abstract:
The present invention relates to methods for producing a hyaluronic acid, comprising: (a) cultivating a host cell under conditions suitable for production of the hyaluronic acid, wherein the host cell comprises a nucleic acid construct comprising a hyaluronan synthase encoding sequence operably linked to a promoter sequence foreign to the hyaluronan synthase encoding sequence; and (b) recovering the hyaluronic acid from the cultivation medium. The present invention also relates to an isolated nucleic acid sequence encoding a hyaluronan synthase operon comprising a hyaluronan synthase gene and a UDP-glucose 6-dehydrogenase gene, and optionally one or more genes selected from the group consisting of a UDP-glucose pyrophosphorylase gene, UDP-N-acetylglucosamine pyrophosphorylase gene, and glucose-6-phosphate isomerase gene. The present invention also relates to isolated nucleic acid sequences encoding a UDP-glucose 6-dehydrogenase, UDP-glucose pyrophosphorylase, and UDP-N-acetylglucosamine pyrophosphorylase

Isbn (Books And Publications)

How To Complete And Survive A Doctoral Dissertation

Author:
David Sternberg
ISBN #:
0312396066

How To Complete And Survive A Doctoral Dissertation

Author:
David Sternberg
ISBN #:
0312396058

Radical Sociology: An Introduction To American Behavioral Science

Author:
David Joel Sternberg
ISBN #:
0682488070

Possible Relatives

Cynthia M Sternberg  Debra J Sternberg  Aaron R Sternberg  Doris A Sternberg  Douglas A Sternberg  Edward S Sternberg  Edwin Q Sternberg  David Last  David W Johnson  David Stamps 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.